Leslie Shaw to Radiation-Protective Agents
This is a "connection" page, showing publications Leslie Shaw has written about Radiation-Protective Agents.
Connection Strength
0.637
-
Bonner HS, Shaw LM. New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion. J Clin Pharmacol. 2002 Feb; 42(2):166-74.
Score: 0.194
-
Bonner HS, Shaw LM. Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2000 Mar 10; 739(2):357-62.
Score: 0.170
-
Shaw LM, Bonner H, Lieberman R. Pharmacokinetic profile of amifostine. Semin Oncol. 1996 Aug; 23(4 Suppl 8):18-22.
Score: 0.133
-
Brown DQ, Graham WJ, MacKenzie LJ, Pittock JW, Shaw LM. Can WR-2721 be improved upon? Pharmacol Ther. 1988; 39(1-3):157-68.
Score: 0.073
-
Shaw LM, Turrisi AT, Glover DJ, Bonner HS, Norfleet AL, Weiler C, Kligerman MM. Human pharmacokinetics of WR-2721. Int J Radiat Oncol Biol Phys. 1986 Aug; 12(8):1501-4.
Score: 0.066